Session Details

F061 Giving a Great Talk: On Zoom or in the Room

Sat, Mar 9, 1:00 PM - 3:00 PM
Room 3
2 CME Available Forum NEW
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Nervous about giving talks? Don't know where to start? Not sure if you can stand up and deliver in front of an audience? Creating and delivering an effective talk is a learnable skill! This session provides the information and strategies you need to prepare effective presentations. We will present a high yield overview of three essential components of giving a talk (conceptualization, slide development and delivery). We will include new information about speaking to a virtual or hybrid in-person and online audience. The session is intended to be interactive and is appropriate for current and aspiring leaders, and anyone who gives talks and lectures at any level.

LEARNING OBJECTIVES

1.

Conceptualize and create a presentation using current and effective educational concepts and approaches.

2.

Develop slides that maximally enhance your presentation.

3.

Deliver an effective presentation to a medical audience by optimally presenting yourself and your content both in person and in virtual presentations.

SPEAKERS

Kelly M. Cordoro, MD, FAAD

Kelly M. Cordoro, MD, FAAD

Ilona J. Frieden, MD, FAAD

Ilona J. Frieden, MD, FAAD

Wilson Liao, MD, FAAD

Wilson Liao, MD, FAAD

Kanade Shinkai, MD, PhD, FAAD

Kanade Shinkai, MD, PhD, FAAD

SPEAKER DISCLOSURES

Kelly M. Cordoro, MD, FAAD

No financial relationships exist with ineligible companies.

Ilona J. Frieden, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);

Wilson Liao, MD, FAAD

Amgen – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding);

Kanade Shinkai, MD, PhD, FAAD

No financial relationships exist with ineligible companies.